(Q30959027)

27 June 2017

1 reference

title

Data quality management in pharmacovigilance (English)

1 reference

27 June 2017

0 references

Marie Lindquist

1

1 reference

27 June 2017

publication date

1 January 2004

1 reference

27 June 2017

1 reference

27 June 2017

volume

27

1 reference

27 June 2017

issue

12

1 reference

27 June 2017

page(s)

857-870

1 reference

Principles of signal detection in pharmacovigilance

27 June 2017

cites work

1 reference

12 December 2020

The New Zealand Intensive Medicines Monitoring Programme.

1 reference

12 December 2020

A population based case-cohort study of drug-induced anaphylaxis

1 reference

12 December 2020

A Bayesian neural network method for adverse drug reaction signal generation.

1 reference

12 December 2020

Physician reporting of adverse drug reactions. Results of the Rhode Island Adverse Drug Reaction Reporting Project

1 reference

12 December 2020

Proactive safety surveillance

1 reference

12 December 2020

Reporting of adverse drug reactions by hospital doctors and the response to intervention

1 reference

12 December 2020

Quality management of pharmacology and safety pharmacology studies

1 reference

12 December 2020

Rates of spontaneous reporting of adverse drug reactions in France

1 reference

12 December 2020

Methods and pitfalls in searching drug safety databases utilising the Medical Dictionary for Regulatory Activities (MedDRA).

1 reference

12 December 2020

A retrospective evaluation of a data mining approach to aid finding new adverse drug reaction signals in the WHO international database

1 reference

12 December 2020

Use of proportional reporting ratios (PRRs) for signal generation from spontaneous adverse drug reaction reports

1 reference

12 December 2020

Biostatistical considerations in pharmacovigilance and pharmacoepidemiology: linking quantitative risk assessment in pre-market licensure application safety data, post-market alert reports and formal epidemiological studies

1 reference

12 December 2020

From pharmacovigilance to pharmacoperformance

1 reference

12 December 2020

Concepts in risk-benefit assessment. A simple merit analysis of a medicine?

1 reference

12 December 2020

An incident reporting system: documented at the point of service

1 reference

12 December 2020

Attitude survey of adverse drug-reaction reporting by health care professionals across the European Union. The European Pharmacovigilance Research Group

1 reference

12 December 2020

Spontaneous ADR reporting and drug safety signal induction in perspective. To honour Professor Jens Schou

1 reference

12 December 2020

The medical dictionary for regulatory activities (MedDRA).

1 reference

12 December 2020

Record linkage studies for postmarketing drug surveillance: data quality and validity considerations.

1 reference

12 December 2020

A comparison of measures of disproportionality for signal detection in spontaneous reporting systems for adverse drug reactions.

1 reference

12 December 2020

International pharmacovigilance: developing cooperation to meet the challenges of the 21st century.

1 reference

12 December 2020

Data quality in post-marketing surveillance.

1 reference

12 December 2020

An ADR surveillance program: increasing quality, number of incidence reports.

1 reference

12 December 2020

Pharmacovigilance: paradise lost, regained or postponed? The William Withering Lecture 1994.

1 reference

12 December 2020

10.2165/00002018-200427120-00003

Identifiers

DOI

1 reference

Dimensions Publication ID

27 June 2017

1048007662

0 references

1 reference